Stay updated on Nivolumab in Pediatric Hypermutant Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.

Latest updates to the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and adds Revision: v3.3.2; the previous PubMed note and Revision: v3.2.0 wording were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedDeleted the funding-status notice about potential information delays and the NIH Clinical Center's operating status.SummaryDifference0.4%

- Check42 days agoChange DetectedThe update appears to be cosmetic UI/formatting changes with no modification to core study details such as title, conditions, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.SummaryDifference2%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no other substantive changes to the core content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Pediatric Hypermutant Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Pediatric Hypermutant Cancers Clinical Trial page.